Ottawa Hospital Research Institute

Research News

Information for patients: Chemo and blood stem cell transplantation for rare autoimmune diseases January 4, 2017 - A number of media stories have recently highlighted The Ottawa Hospital’s use of chemotherapy and blood stem cell transplantation to treat rare autoimmune diseases, such as myasthenia gravis, stiff person syndrome and scleroderma. These stories have

Researchers in Ottawa achieve breakthrough with rare disease: Stem cells used to send “stiff person syndrome” into long-term remission August 25, 2014 - Ottawa—Scientists at The Ottawa Hospital Research Institute have made a breakthrough in the successful treatment of a rare and debilitating neurological disease known as stiff person syndrome that leaves people who are afflicted with the disorder sta

Researchers

Name	Scientific appointment	Diseases, conditions and populations of interest	Research and clinical approaches
Atkins, Harold MD, FRCPC	Senior Clinician Investigator (CR)	Autoimmune disease, Autoimmune diseases of the nervous system, Blood cancer, Cancer, Multiple sclerosis, Myasthenia gravis, Stiff person syndrome	Basic research, Cancer biotherapeutics, Cancer immunotherapy, Cell therapy, Clinical trials, Immunotherapy, Oncolytic viruses, Regenerative medicine, Stem cells, Translational research, Transplantation, Viral therapy
Warman Chardon, Jodi MD, PhD FRCPC (Neurology)	Associate Scientist (NS)	Amyotrophic lateral sclerosis, Genetic myopathy, Muscular dystrophy, Neuromuscular disease, Spinal muscular atrophy, Stiff person syndrome	Artificial intelligence and data science, Clinical research, Clinical trials, Exome sequencing analysis, Genetics, Imaging, MRI muscle imaging, Next generation sequencing, RNA sequencing, Genetics

Related Resources

Search for clinical trials at The Ottawa Hospital related to this disease or condition.